These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34427958)

  • 1. Sodium channel blockers in the management of long QT syndrome types 3 and 2: A system review and meta-analysis.
    Yang Y; Lv TT; Li SY; Zhang P
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3057-3067. PubMed ID: 34427958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.
    Bos JM; Crotti L; Rohatgi RK; Castelletti S; Dagradi F; Schwartz PJ; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007280. PubMed ID: 31006312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
    Schwartz PJ; Priori SG; Locati EH; Napolitano C; Cantù F; Towbin JA; Keating MT; Hammoude H; Brown AM; Chen LS; Colatsky TJ
    Circulation; 1995 Dec; 92(12):3381-6. PubMed ID: 8521555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.
    Wong JA; Gula LJ; Klein GJ; Yee R; Skanes AC; Krahn AD
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):120-5. PubMed ID: 20071715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular basis for the therapy of the long QT syndrome.
    Priori SG; Napolitano C; Schwartz PJ
    Arch Mal Coeur Vaiss; 1996 Sep; 89(9):1185-7. PubMed ID: 8952843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
    Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
    Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-specific effect of beta-adrenergic blockade on corrected QT interval in the long QT syndrome.
    Extramiana F; Maison-Blanche P; Denjoy I; De Jode P; Messali A; Labbé JP; Leenhardt A
    Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):399-408. PubMed ID: 23879280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome.
    Funasako M; Aiba T; Ishibashi K; Nakajima I; Miyamoto K; Inoue Y; Okamura H; Noda T; Kamakura S; Anzai T; Noguchi T; Yasuda S; Miyamoto Y; Fukushima Kusano K; Ogawa H; Shimizu W
    Circ J; 2016; 80(2):340-5. PubMed ID: 26632536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.
    Chorin E; Hu D; Antzelevitch C; Hochstadt A; Belardinelli L; Zeltser D; Barajas-Martinez H; Rozovski U; Rosso R; Adler A; Benhorin J; Viskin S
    Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome.
    Noda T; Takaki H; Kurita T; Suyama K; Nagaya N; Taguchi A; Aihara N; Kamakura S; Sunagawa K; Nakamura K; Ohe T; Horie M; Napolitano C; Towbin JA; Priori SG; Shimizu W
    Eur Heart J; 2002 Jun; 23(12):975-83. PubMed ID: 12069453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.
    Shimizu W; Aiba T; Antzelevitch C
    Curr Pharm Des; 2005; 11(12):1561-72. PubMed ID: 15892662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-specific risk stratification and management of patients with long QT syndrome.
    Barsheshet A; Dotsenko O; Goldenberg I
    Ann Noninvasive Electrocardiol; 2013 Nov; 18(6):499-509. PubMed ID: 24206565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.
    Priori SG; Napolitano C; Schwartz PJ; Grillo M; Bloise R; Ronchetti E; Moncalvo C; Tulipani C; Veia A; Bottelli G; Nastoli J
    JAMA; 2004 Sep; 292(11):1341-4. PubMed ID: 15367556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Provocative Testing in the Diagnosis and Genotyping of Congenital Long QT Syndrome: A Systematic Review and Meta-Analysis.
    Yang Y; Lv TT; Li SY; Liu P; Gao QG; Zhang P
    J Am Heart Assoc; 2022 Jul; 11(14):e025246. PubMed ID: 35861842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Therapy Based on the Genotype in a Malignant Form of Long QT3, Carrying the V411M Mutation.
    Blich M; Khoury A; Suleiman M; Lorber A; Gepstein L; Boulous M
    Int Heart J; 2019 Jul; 60(4):979-982. PubMed ID: 31257342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
    Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of a simplified lidocaine and potassium infusion in diagnosing long QT syndrome among patients with borderline QTc interval prolongation.
    Chauhan VS; Krahn AD; Klein GJ; Skanes AC; Yee R
    Ann Noninvasive Electrocardiol; 2004 Jan; 9(1):12-8. PubMed ID: 14731211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.